Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In...

Published on 15 Apr 2024 on Benzinga

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In...

Shares of Ultragenyx Pharmaceutical Inc. RARE fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday.

Read the rest of the article

NASDAQ.RARE price evolution

NASDAQ.WIRE price evolution

NASDAQ.PLL price evolution

NASDAQ.LGVN price evolution

ASX.GTG price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

30 years ago Tomorrow's World predicted 2025 - how did it do?

Can you see the black blob? While filming this sequence, Vivienne Parry and the make-up team...th...

BBC · via Yahoo News 1 Jan 2025

Is Prime Medicine (PRME) Among the Top CRISPR Stocks to Invest In?

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are goi...

Insider Monkey · via Yahoo Finance 1 Jan 2025

Genomic Analysis Reveals Hainan Tea as a Unique Va | Newswise

A research team conducted a large-scale genetic study by collecting 500 samples from Hainan’s maj...

Newswise 30 Dec 2024

Prime Medicine, Inc. (PRME): Is This Gene Therapy Stock a Good Buy Right Now?

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article,...

Insider Monkey · via Yahoo Finance 29 Dec 2024

Genetic testing helps B.C. hereditary cancer survivor break the cycle

Natasha Benn lost her sister to a rare and aggressive form of stomach cancer in 1993. Before Nico...

Houston Today 29 Dec 2024

The vitamin con: Do supplements do anything or are we all being scammed?

LET’S UNPACK THAT: As we all embark on yet another ‘New Year, New You’ journey, Helen Coffey asks...

The Independent US · via AOL 28 Dec 2024

2024 was 'year of the cancer vaccine' - top experts explain breakthroughs

Cancer experts have hailed 2024 as the “year of the cancer vaccine” in celebration of an explosio...

Daily Express 28 Dec 2024

3 Promising Penny Stocks With At Least US$100M Market Cap

As global markets navigate cautious Federal Reserve commentary and political uncertainties,...

Simply Wall St. · via Yahoo Finance 27 Dec 2024

Previously unusable DNA is evidence in the murder trial of N.J. uncle accused of...

Lawyers for Paul Caneiro who is charged with the brutal murders of four of his relatives are...

NBC Universal · via AOL 27 Dec 2024

Previously unusable DNA sample now evidence in the quadruple murder trial of...

Lawyers for Paul Caneiro who is charged with the brutal murders of four of his relatives are...

NBC News · via Yahoo News 27 Dec 2024